Bioheart to Present At the Cell & Gene Therapy Forum in Washington, D.C.
22 janv. 2009 08h00 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 22, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure...
Bioheart, Inc. Elects Dr. Karl Groth to Its Board of Directors and Appoints Peggy Farley to Chairman of the Audit Committee
20 janv. 2009 21h32 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 20, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced that it has elected Dr. Karl Groth, a co-founder of the Ascent Medical Technology Fund, to its Board of...
Bioheart, Inc. Reports Receipt of Notification From NASDAQ Regarding Non-Compliance With Continued Listing Requirements
20 janv. 2009 16h35 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 20, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) today announced that it received a letter from the Nasdaq Stock Market on January 14, 2009 advising that, the Company does...
Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients
14 janv. 2009 10h54 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT)
announced today it has received a purchase order for a TGI 1200 System from
Philadelphia BioMed Product Development...
Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients
14 janv. 2009 10h35 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has received a purchase order for a TGI 1200 System from Philadelphia BioMed Product Development...
Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
13 janv. 2009 10h52 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT)
announced today it has filed with appropriate agencies in Switzerland for
reimbursement approval for its MyoCell(r)...
Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
13 janv. 2009 10h42 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has filed with appropriate agencies in Switzerland for reimbursement approval for its MyoCell(r)...
Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure
12 janv. 2009 23h52 HE
|
Bioheart, Inc.
Four Years of Sponsored Animal Studies At Cleveland Clinic and the University
of Florida Have Demonstrated That Second-generation Cell Therapy, MyoCell(r)
SDF-1, Provides Double the Level of...
Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure
12 janv. 2009 10h07 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 12, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today that it plans to conduct clinical trials for its second-generation MyoCell SDF-1 myogenic cell composition...
Bioheart Collaborating Researchers to Present At the Fifth International Conference on Cell Therapy for Cardiovascular Disease in New York, January 14-16, 2009
09 janv. 2009 13h56 HE
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company developing core technologies aimed at serving the heart failure patient population, announced today that eight...